Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22987 | 24133663 | Clin Mol Hepatol | Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. | 2013 | Details |
| A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22992 | 24131545 | QJM | Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management. | 2013 | Details |
| A22996 | 24129399 | Am J Physiol Endocrinol Metab | Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. | 2013 | Details |
| A22997 | 24127654 | Curr Med Res Opin | Are statins 'IDEAL' for non-alcoholic fatty liver disease? | 2013 | Details |
| A22998 | 24126888 | Lab Invest | Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. | 2013 | Details |
| A23000 | 24123276 | Hepatology | Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A23009 | 24118921 | Hepatol Res | Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damage. | 2013 | Details |
| A23011 | 24118743 | Liver Int | Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. | 2013 | Details |
| A23013 | 24117728 | Aliment Pharmacol Ther | Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. | 2013 | Details |
| A23016 | 24115128 | Hepatology | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. | 2014 | Details |
| A23020 | 24113768 | Am J Physiol Gastrointest Liver Physiol | Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. | 2013 | Details |
| A23021 | 24113587 | Int J Mol Sci | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. | 2013 | Details |
| A23022 | 24107103 | Liver Int | Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. | 2013 | Details |
| A23026 | 24100261 | Am J Gastroenterol | Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. | 2013 | Details |
| A23030 | 24098525 | PLoS One | Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis. | 2013 | Details |
| A23038 | 24084729 | Int J Mol Sci | Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. | 2013 | Details |
| A23062 | 24071521 | Life Sci | High-fat-cholesterol diet mainly induced necrosis in fibrotic steatohepatitis rat by suppressing caspase activity. | 2013 | Details |
| A23063 | 24071517 | Mol Cell Endocrinol | Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. | 2013 | Details |
| A23064 | 24070151 | Expert Rev Gastroenterol Hepatol | Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review. | 2013 | Details |
| A23067 | 24068459 | Eur J Pediatr | Pediatric non-alcoholic fatty liver disease: an increasing public health issue. | 2013 | Details |
| A23068 | 24067262 | Ann Hepatol | Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. | 2014 | Details |
| A23070 | 24066058 | PLoS One | Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
| A23078 | 24064151 | J Pediatr | Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. | 2013 | Details |
| A23079 | 24061205 | Nat Rev Gastroenterol Hepatol | The genetics of NAFLD. | 2013 | Details |
| A23080 | 24061203 | Nat Rev Gastroenterol Hepatol | Noninvasive evaluation of NAFLD. | 2013 | Details |
| A23081 | 24059726 | Mini Rev Med Chem | Hepatic diseases related to triglyceride metabolism. | 2013 | Details |
| A23085 | 24053454 | BMC Gastroenterol | The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review. | 2013 | Details |
| A23089 | 24048504 | Med Mol Morphol | Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis. | 2013 | Details |
| A23101 | 24040873 | Curr Pharm Des | The role of oral antidiabetic agents and incretin mimetics in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A23103 | 24039933 | PLoS One | Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. | 2013 | Details |
| A23104 | 24039859 | PLoS One | Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. | 2013 | Details |
| A23108 | 24036007 | J Hepatol | Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. | 2013 | Details |
| A23112 | 24033085 | Eur J Clin Invest | Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. | 2013 | Details |
| A23113 | 24030232 | Dig Dis | Liver complications in inflammatory bowel diseases. | 2013 | Details |
| A23114 | 24029696 | Kidney Blood Press Res | Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography. | 2013 | Details |
| A23116 | 24028214 | Liver Int | Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. | 2013 | Details |
| A23125 | 24020975 | Curr Drug Targets | Biomarkers for early detection of non-alcoholic steatohepatitis: implications for drug development and clinical trials. | 2013 | Details |
| A23133 | 24015600 | Adv Clin Chem | Markers in nonalcoholic steatohepatitis. | 2013 | Details |
| A23135 | 24011648 | Gastroenterol Hepatol | [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. | 2013 | Details |
| A23155 | 23998651 | Liver Int | Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. | 2013 | Details |
| A23161 | 23996518 | Horm Metab Res | Olive oil attenuates the cholesterol-induced development of nonalcoholic steatohepatitis despite increased insulin resistance in a rodent model. | 2013 | Details |
| A23164 | 25755505 | J Clin Exp Hepatol | MicroRNAs in Liver Disease: Bench to Bedside. | 2013 | Details |
| A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
| A23171 | 23985000 | Expert Rev Gastroenterol Hepatol | Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already? | 2013 | Details |
| A23180 | 23981577 | Cancer Lett | Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. | 2013 | Details |
| A23185 | 23978414 | Food Chem Toxicol | Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. | 2013 | Details |
| A23191 | 23973932 | J Hepatol | Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23204 | 23961483 | Indian J Endocrinol Metab | Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? | 2013 | Details |
| A23205 | 23960084 | Mol Endocrinol | Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD. | 2013 | Details |
| A23206 | 23959503 | Hepatology | Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. | 2014 | Details |
| A23208 | 23958600 | Nat Rev Gastroenterol Hepatol | The Gordian Knot of dysbiosis, obesity and NAFLD. | 2013 | Details |
| A23209 | 23958599 | Nat Rev Gastroenterol Hepatol | From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. | 2013 | Details |
| A23226 | 23940130 | J Clin Pathol | Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2013 | Details |
| A23233 | 23935128 | Eur J Endocrinol | Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. | 2013 | Details |
| A23234 | 23934335 | Obes Surg | Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery? | 2014 | Details |
| A23235 | 23933938 | Hepatogastroenterology | Long-term (>=2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis. | 2013 | Details |
| A23236 | 23933265 | J Hepatol | Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. | 2013 | Details |
| A23239 | 23932277 | Ultrasound Med Biol | Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23246 | 23929039 | Int J Cancer | Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. | 2013 | Details |
| A23252 | 23924495 | Hepatobiliary Pancreat Dis Int | Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. | 2013 | Details |
| A23253 | 23923372 | Trop Gastroenterol | Fibrosis in non-alcoholic fatty liver disease: correlation with simple blood indices and association with tumor necrosis factor-alpha polymorphisms. | 2013 | Details |
| A23258 | 23922466 | World J Gastroenterol | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. | 2013 | Details |
| A23264 | 23917437 | Nutr Clin Pract | Pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23265 | 23916847 | Gastroenterology | Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23267 | 23915028 | Free Radic Res | Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? | 2013 | Details |
| A23272 | 23913408 | Hepatology | Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. | 2013 | Details |
| A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
| A23283 | 23898557 | Acta Gastroenterol Belg | Treatment of non-alcoholic fatty liver disease: can we already face the epidemic? | 2013 | Details |
| A23284 | 26405460 | Clin Lipidol | Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis. | 2013 | Details |
| A23286 | 23897284 | Nat Rev Gastroenterol Hepatol | NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis. | 2013 | Details |
| A23292 | 23894677 | PLoS One | Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. | 2013 | Details |
| A23293 | 23894275 | PLoS One | Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease. | 2013 | Details |
| A23294 | 23891824 | Gene | Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients. | 2013 | Details |
| A23298 | 23886860 | Am J Physiol Gastrointest Liver Physiol | Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. | 2013 | Details |
| A23311 | 23855304 | J Gastroenterol Hepatol | Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease. | 2013 | Details |
| A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
| A23315 | 23855294 | J Gastroenterol Hepatol | Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. | 2013 | Details |
| A23319 | 23873346 | Curr Opin Clin Nutr Metab Care | The gut-liver axis. | 2013 | Details |
| A23325 | 23870067 | Liver Int | Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. | 2013 | Details |
| A23332 | 23865141 | J Pak Med Assoc | Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease. | 2013 | Details |
| A23333 | 23864802 | Korean J Intern Med | Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23334 | 23862644 | Annu Rev Nutr | Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. | 2013 | Details |
| A23339 | 23860502 | Gastroenterology | Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23341 | 23859493 | J Dig Dis | Performance of transient elastography (TE) and factors associated with discordance in non-alcoholic fatty liver disease. | 2013 | Details |
| A23346 | 23853345 | Orv Hetil | [Non-alcoholic fatty liver disease and steatohepatitis]. | 2013 | Details |
| A23360 | 23843692 | Drug Des Devel Ther | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. | 2013 | Details |
| A23366 | 23840612 | PLoS One | Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23368 | 23840139 | World J Gastroenterol | Exposure to ambient air particulate matter and non-alcoholic fatty liver disease. | 2013 | Details |
| A23370 | 23837136 | Clin Mol Hepatol | Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease. | 2013 | Details |
| A23381 | 23831119 | J Hepatol | Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. | 2013 | Details |
| A23401 | 23812039 | Am J Physiol Gastrointest Liver Physiol | Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease. | 2013 | Details |
| A23406 | 26201914 | Hepatol Int | Detecting fibrosis without a liver biopsy: getting to the fat of the issue. | 2013 | Details |
| A23407 | 25332959 | Ann Transl Med | New insights in hepatocellular carcinoma: from bench to bedside. | 2013 | Details |
| A23411 | 23805214 | PLoS One | Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. | 2013 | Details |
| A23415 | 23803374 | Hepatogastroenterology | Serum liver fatty acid binding protein shows good correlation with liver histology in NASH. | 2014 | Details |
| A23419 | 23800943 | J Gastroenterol | Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. | 2013 | Details |
| A23420 | 23799213 | J Gastrointestin Liver Dis | The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease. | 2013 | Details |
| A23422 | 23798324 | Liver Transpl | Liver transplantation with a strongly positive crossmatch: case study and literature review. | 2013 | Details |
| A23435 | 23786840 | Acta Biochim Biophys Sin (Shanghai) | Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. | 2013 | Details |